- Home
- MNPR vs ACNB Comparison
MNPR vs ACNB Comparison
Compare MNPR & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- ACNB
- Stock Information
- Founded
- MNPR 2014
- ACNB 1857
- Country
- MNPR United States
- ACNB United States
- Employees
- MNPR N/A
- ACNB N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- MNPR Health Care
- ACNB Finance
- Exchange
- MNPR Nasdaq
- ACNB Nasdaq
- Market Cap
- MNPR 531.6M
- ACNB 468.6M
- IPO Year
- MNPR 2019
- ACNB N/A
- Fundamental
- Price
- MNPR $92.78
- ACNB $48.40
- Analyst Decision
- MNPR Strong Buy
- ACNB Strong Buy
- Analyst Count
- MNPR 13
- ACNB 3
- Target Price
- MNPR $97.83
- ACNB $50.67
- AVG Volume (30 Days)
- MNPR 161.9K
- ACNB 18.7K
- Earning Date
- MNPR 11-13-2025
- ACNB 10-23-2025
- Dividend Yield
- MNPR N/A
- ACNB 3.14%
- EPS Growth
- MNPR N/A
- ACNB N/A
- EPS
- MNPR N/A
- ACNB 3.34
- Revenue
- MNPR N/A
- ACNB $136,676,000.00
- Revenue This Year
- MNPR N/A
- ACNB $41.47
- Revenue Next Year
- MNPR N/A
- ACNB $3.31
- P/E Ratio
- MNPR N/A
- ACNB $14.48
- Revenue Growth
- MNPR N/A
- ACNB 28.45
- 52 Week Low
- MNPR $18.67
- ACNB $35.70
- 52 Week High
- MNPR $105.00
- ACNB $49.25
- Technical
- Relative Strength Index (RSI)
- MNPR 64.12
- ACNB 62.85
- Support Level
- MNPR $74.58
- ACNB $45.64
- Resistance Level
- MNPR $84.06
- ACNB $48.54
- Average True Range (ATR)
- MNPR 6.71
- ACNB 1.47
- MACD
- MNPR 0.32
- ACNB 0.01
- Stochastic Oscillator
- MNPR 95.22
- ACNB 91.11
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.